Runben Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Runben Biotechnology has a total shareholder equity of CN¥2.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.2B and CN¥177.3M respectively. Runben Biotechnology's EBIT is CN¥300.3M making its interest coverage ratio -7. It has cash and short-term investments of CN¥396.3M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -7x |
| Cash | CN¥396.33m |
| Equity | CN¥2.04b |
| Total liabilities | CN¥177.32m |
| Total assets | CN¥2.22b |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: 603193's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥175.2M).
Long Term Liabilities: 603193's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥2.1M).
Debt to Equity History and Analysis
Debt Level: 603193 is debt free.
Reducing Debt: 603193 has not had any debt for past 5 years.
Debt Coverage: 603193 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 603193 has no debt, therefore coverage of interest payments is not a concern.